Mining gene expression data for rational identification of novel drug targets and vaccine candidates against the cattle tick, Rhipicephalus microplus
- PMID: 37755526
- PMCID: PMC10562289
- DOI: 10.1007/s10493-023-00838-8
Mining gene expression data for rational identification of novel drug targets and vaccine candidates against the cattle tick, Rhipicephalus microplus
Abstract
Control of complex parasites via vaccination remains challenging, with the current combination of vaccines and small drugs remaining the choice for an integrated control strategy. Studies conducted to date, are providing evidence that multicomponent vaccines will be needed for the development of protective vaccines against endo- and ectoparasites, though multicomponent vaccines require an in-depth understanding of parasite biology which remains insufficient for ticks. With the rapid development and spread of acaricide resistance in ticks, new targets for acaricide development also remains to be identified, along with novel targets that can be exploited for the design of lead compounds. In this study, we analysed the differential gene expression of Rhipicephalus microplus ticks that were fed on cattle vaccinated with a multi-component vaccine (Bm86 and 3 putative Bm86-binding proteins). The data was scrutinised for the identification of vaccine targets, small drug targets and novel pathways that can be evaluated in future studies. Limitations associated with targeting novel proteins for vaccine and/or drug design is also discussed and placed into the context of challenges arising when targeting large protein families and intracellular localised proteins. Lastly, this study provide insight into how Bm86-based vaccines may reduce successful uptake and digestion of the bloodmeal and overall tick fecundity.
Keywords: Rhipicephalus microplus; Antigen selection; Bm86; DNA microarray; Drug target identification; Multicomponent vaccine.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Fourteen anti-tick vaccine targets are variably conserved in cattle fever ticks.Parasit Vectors. 2025 Apr 15;18(1):140. doi: 10.1186/s13071-025-06683-5. Parasit Vectors. 2025. PMID: 40234925 Free PMC article.
-
High efficacy of a 20 amino acid peptide of the acidic ribosomal protein P0 against the cattle tick, Rhipicephalus microplus.Ticks Tick Borne Dis. 2015 Jun;6(4):530-7. doi: 10.1016/j.ttbdis.2015.04.007. Epub 2015 Apr 28. Ticks Tick Borne Dis. 2015. PMID: 25958782
-
Two initial vaccinations with the Bm86-based Gavacplus vaccine against Rhipicephalus (Boophilus) microplus induce similar reproductive suppression to three initial vaccinations under production conditions.BMC Vet Res. 2010 Sep 16;6:43. doi: 10.1186/1746-6148-6-43. BMC Vet Res. 2010. PMID: 20846415 Free PMC article.
-
Immunological control of ticks and tick-borne diseases that impact cattle health and production.Front Biosci (Landmark Ed). 2018 Mar 1;23(8):1535-1551. doi: 10.2741/4659. Front Biosci (Landmark Ed). 2018. PMID: 29293449 Review.
-
Rhipicephalus (Boophilus) microplus embryo proteins as target for tick vaccine.Vet Immunol Immunopathol. 2012 Jul 15;148(1-2):149-56. doi: 10.1016/j.vetimm.2011.05.011. Epub 2011 May 7. Vet Immunol Immunopathol. 2012. PMID: 21620488 Review.
Cited by
-
Aurora kinase as a putative target to tick control.Parasitology. 2024 Aug;151(9):983-991. doi: 10.1017/S003118202400101X. Epub 2024 Nov 15. Parasitology. 2024. PMID: 39542861 Free PMC article.
-
Fourteen anti-tick vaccine targets are variably conserved in cattle fever ticks.Parasit Vectors. 2025 Apr 15;18(1):140. doi: 10.1186/s13071-025-06683-5. Parasit Vectors. 2025. PMID: 40234925 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases